Medicare Covers Microvolt T-Wave Alternans Testing
Cardiology News in Context
Free Article
But coverage does not, in itself, confirm the value of MTWA testing for identifying who will benefit from an implantable cardioverter-defibrillator.
By Hugh Calkins, MD
April 27, 2006
ICD Update: Recalls and a Registry
Cardiology News in Context
Free Article
A recall update plus information about a confidential quality-measurement program for implantable cardioverter-defibrillators
By Hugh Calkins, MD
November 25, 2005
Responding to the Recent Pacemaker Recalls
Cardiology News in Context
Free Article
On July 22, the FDA issued a Class I recall for certain pacemakers manufactured by Guidant Corporation (see http://www.fda.gov/bbs/topics/NEWS/2005/NEW01210.html ). A Class I recall means . . .
By Hugh Calkins, MD
August 5, 2005
Responding to the Recent ICD Recalls
Cardiology News in Context
Free Article
What are the considerations in deciding whether to replace a recalled implantable cardioverter-defibrillator?
By Hugh Calkins, MD
August 5, 2005
Expert Panel's Views on Nesiritide
Cardiology News in Context
Free Article
After concerns were raised this spring about renal and mortality risks from nesiritide (Natrecor; see Journal Watch Cardiology May 6 2005 ), the drug's manufacturer . . .
By Harlan M. Krumholz, MD, SM
July 1, 2005
Perspective on the News About Nesiritide
Cardiology News in Context
Free Article
Mortality data in the revised package insert for nesiritide are at odds with mortality data from a recently published meta-analysis of nesiritide trials.
By Harlan M. Krumholz, MD, SM
May 6, 2005
Perspective on the News About Naproxen
Cardiology News in Context
Subscription Required
On December 23, 2004, the FDA issued an alert for healthcare providers about the nonsteroidal anti-inflammatory drug (NSAID) naproxen (see http://www.fda.gov/cder/drug/InfoSheets/HCP/Naproxen-hcp.pdf ). The alert was . . .
By Harlan M. Krumholz, MD, SM
April 1, 2005
